From light to healing: photobiomodulation therapy in medical disciplines.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and clinical literature
PubMed 41466382 · doi:10.1186/s12967-025-07466-3
What was done
The authors conducted a literature search across Google Scholar, Scopus, PubMed, and Web of Science to evaluate recent mechanistic and clinical research on photobiomodulation therapy (PBMT). The review analyzed cellular mechanisms—including cytochrome c oxidase-mediated energy transduction, reactive oxygen species, nitric oxide signaling, and cytokine regulation—across specialties including dermatology, neurology, ophthalmology, oncology, and musculoskeletal conditions.
What was found
The abstract reports no numerical data or pooled statistical outcomes. Qualitatively, PBMT was reported to influence cellular metabolism and immune balance, offering potential benefit for symptom alleviation and tissue protection during oxidative or inflammatory stress. However, outcomes are context-dependent, showing negative or equivocal results in trained or low-stress cohorts alongside persistent issues with non-standardized dosimetry, variable energy delivery, and heterogeneous endpoints.
Why it matters
This review links fundamental mitochondrial photochemistry with clinical applications, highlighting that clinical utility will remain inconsistent until dosimetric standards and personalized optical modeling are established.
Limits
The abstract contains no quantitative metrics, effect sizes, or study counts. As a broad narrative review covering mechanistic models and disparate clinical indications, it lacks systematic meta-analytic synthesis and formal risk-of-bias evaluation.